EFX Stock Recent News

EFX's fourth-quarter 2024 revenues are expected to have increased due to healthy mortgage activities.

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Equifax (EFX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024.

Equifax (EFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Company's stock surged over 100% after positive 96-week results from its phase 2b SYMMETRY study using EFX to treat F4 compensated cirrhosis due to MASH patients. The company achieved a significant reversal of cirrhosis, with 39% of patients showing improvement compared to 15% on placebo, highlighting EFX's efficacy. Upcoming catalysts include phase 3 SYNCHRONY studies targeting F1-F3 and F2-F3 MASH patients, with data expected in the first half of 2026 and 2027, respectively.

ATLANTA , Jan. 22, 2025 /PRNewswire/ -- Equifax ® (NYSE: EFX) will announce its financial results for the fourth quarter ended December 31, 2024, in a release to be issued on Thursday, February 6, at 6:30 a.m. Eastern Time (ET).

Equifax has agreed to a settlement and consent order that will resolve Consumer Financial Protection Bureau (CFPB) allegations that the consumer reporting agency failed to take steps to ensure the accuracy of its credit reports.

The U.S. Consumer Financial Protection Bureau announced on Friday it had fined credit reporting bureau Equifax $15 million for failing to sufficiently investigate consumer disputes of its credit reports.

Investors interested in stocks from the Consulting Services sector have probably already heard of CRA International (CRAI) and Equifax (EFX). But which of these two stocks offers value investors a better bang for their buck right now?

Equifax's transition to its own cloud and EFX.AI capabilities will drive revenue growth, margin expansion, and increased free cash flow, enhancing profitability. Lower CapEx and higher margins will boost earnings, with EPS expected to grow significantly, supporting a one-year price target of $306.75 and a Strong Buy rating. The new cloud platform will improve productivity, benefiting shareholders with increased returns.

Equifax Inc. (NYSE:EFX ) Q3 2024 Earnings Conference Call October 17, 2024 8:30 AM ET Company Participants Trevor Burns - Senior Vice President, Head of Corporate Investor Relations Mark Begor - Chief Executive Officer John Gamble - Chief Financial Officer Conference Call Participants Manav Patnaik - Barclays Kelsey Zhu - Autonomous Research Andrew Nicholas - William Blair Surinder Thind - Jefferies Kyle Peterson - Needham & Company Scott Wurtzel - Wolfe Research Kevin McVeigh - UBS Jason Haas - Wells Fargo Jeff Meuler - Baird Owen Lau - Oppenheimer Craig Huber - Huber Research Partners Toni Kaplan - Morgan Stanley Ashish Sabadra - RBC Capital Markets George Tong - Goldman Sachs Andrew Stein - FT Partners Operator Greetings, and welcome to the Equifax Inc. Third Quarter 2024 Earnings Conference Call. At this time all participants are in a listen-only mode.